/Companies

株式会社ミルテル

1 known investors

Find your way into 株式会社ミルテル

Sign up to see every warm intro you have to 株式会社ミルテル

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the 株式会社ミルテル team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Mirtel is a Hiroshima University-spinout biotech company offering proprietary genetic and biomarker testing, including telomere-based and saliva-based cancer risk tests, aimed at early disease detection and healthy longevity.

Investors · 1

Frequently asked questions

What does 株式会社ミルテル do?
Mirtel is a Hiroshima University-spinout biotech company offering proprietary genetic and biomarker testing, including telomere-based and saliva-based cancer risk tests, aimed at early disease detection and healthy longevity.
Who are 株式会社ミルテル's investors?
株式会社ミルテル's investors include NTT DOCOMO Ventures.